{"id":7812,"date":"2026-02-24T06:08:29","date_gmt":"2026-02-24T06:08:29","guid":{"rendered":"https:\/\/pandapeptides.com\/research\/glp-2-t\/"},"modified":"2026-04-30T13:12:10","modified_gmt":"2026-04-30T20:12:10","slug":"glp-2","status":"publish","type":"page","link":"https:\/\/pandapeptides.com\/es\/research\/glp-2\/","title":{"rendered":"GLP-2 \u2014 Published Research"},"content":{"rendered":"
\n
\n

How to read this GLP-2 research page<\/h2>\n

Use this page as a literature and documentation map for GLP-2 naming, receptor-model terminology, and batch verification links. It is designed to connect the product page, COA directory, quality standards, and related GLP research pages.<\/p>\n

For comparison across Panda\u2019s GLP catalog, review molecular identity, naming conventions, product documentation, and COA status rather than clinical or consumer-use outcomes.<\/p>\n

Product specs<\/a>\u00b7<\/span>COAs<\/a>\u00b7<\/span>Quality & Testing<\/a>\u00b7<\/span>GLP hub<\/a><\/div>\n

This page does not provide consumer-use, application, procedural, preparation, clinical-use, outcome, or non-research-use guidance.<\/p>\n<\/section>\n

\u2190 Back to GLP-2 product page<\/a><\/p>\n

Ver reportes de laboratorio<\/a> \u00b7 Calidad y pruebas<\/a> \u00b7 Preguntas frecuentes<\/a><\/p>\n

\n

Biblioteca de investigaci\u00f3n<\/h3>\n

Published research on this compound \u2014 for educational purposes only<\/p>\n

\nMechanism as an imbalanced dual agonist<\/summary>\n
\n

GLP-2 is characterized as an “imbalanced” dual agonist because it displays full agonism at the GIP receptor but biased agonism at the GLP-1 receptor. At the GLP-1R, GLP-2 preferentially activates G\u03b1s-mediated cAMP signaling while exhibiting reduced \u03b2-arrestin recruitment compared to native GLP-1. This biased signaling profile results in less receptor internalization and potentially sustained receptor surface availability. The compound’s C-20 fatty diacid moiety enables albumin binding and alters its stability profile in preclinical characterization. For laboratory research use only.<\/em><\/p>\n

Willard FS, et al. JCI Insight.<\/em> 2020;5(17):e140532. JCI Insight<\/a><\/p>\n<\/div>\n<\/details>\n

\nGLP-1R signaling vs selective GLP-1 agonists<\/summary>\n
\n

Unlike selective GLP-1 receptor agonists such as GLP-1 S, GLP-2 demonstrates biased agonism at GLP-1R characterized by reduced \u03b2-arrestin-1 recruitment. Selective GLP-1 agonists activate both cAMP and \u03b2-arrestin pathways with relatively balanced efficacy, leading to robust receptor internalization. GLP-2’s biased profile \u2014 favoring cAMP over \u03b2-arrestin \u2014 may alter receptor trafficking dynamics. The simultaneous engagement of GIP receptors with full agonism distinguishes GLP-2’s pharmacological signature from mono-agonist compounds. For laboratory research use only.<\/em><\/p>\n

Min Q, et al. Proc Natl Acad Sci USA.<\/em> 2022;119(34):e2116506119. PNAS<\/a><\/p>\n<\/div>\n<\/details>\n

\ncAMP vs \u03b2-arrestin receptor pharmacology<\/summary>\n
\n

In cell-based assays, GLP-2 activates GIP receptor-mediated cAMP accumulation with potency comparable to native GIP. At the GLP-1 receptor, GLP-2 generates cAMP with approximately 5-fold lower potency than native GLP-1, but displays markedly reduced (>100-fold) \u03b2-arrestin-1 and \u03b2-arrestin-2 recruitment. This dissociation between G-protein signaling and arrestin recruitment defines GLP-2 as a G-protein-biased agonist at GLP-1R. For laboratory research use only.<\/em><\/p>\n

Willard FS, et al. JCI Insight.<\/em> 2020;5(17):e140532. JCI Insight<\/a><\/p>\n<\/div>\n<\/details>\n

\nStructural basis for dual receptor engagement<\/summary>\n
\n

GLP-2 is a 39-amino acid linear peptide based on the native GIP sequence with modifications enabling GLP-1R cross-reactivity. Key structural features include an \u03b1-aminoisobutyric acid (Aib) substitution at position 2 conferring DPP-4 resistance, and a C-20 fatty diacid moiety conjugated via a linker at lysine-20 enabling non-covalent albumin binding. The exendin-4-derived C-terminal extension (positions 35-39) contributes to GLP-1R engagement. For laboratory research use only.<\/em><\/p>\n

Min Q, et al. Proc Natl Acad Sci USA.<\/em> 2022;119(34):e2116506119. PNAS<\/a><\/p>\n<\/div>\n<\/details>\n<\/div>\n

\n

Continue reviewing GLP-2<\/h3>\n

Use the research references above alongside Panda\u2019s batch documentation and catalog specifications.<\/p>\n

View product specs<\/a>Check COA library<\/a>Quality & testing<\/a>Evaluation guide<\/a>Research library<\/a><\/div>\n<\/div>\n
\n

Disclaimer:<\/strong> All research citations are provided as references to published laboratory literature only. These materials may summarize in vitro and animal-model findings. Products are sold strictly for laboratory research use only. This page is provided for research-reference and documentation review only.<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

How to read this GLP-2 research page Use this page as a literature and documentation map for GLP-2 naming, receptor-model terminology, and batch verification links. It is designed to connect the product page, COA directory, quality standards, and related GLP research pages. For comparison across Panda\u2019s GLP catalog, review molecular identity, naming conventions, product documentation, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":7787,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-7812","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/comments?post=7812"}],"version-history":[{"count":5,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7812\/revisions"}],"predecessor-version":[{"id":9597,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7812\/revisions\/9597"}],"up":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7787"}],"wp:attachment":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/media?parent=7812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}